Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

September 14, 2010 5:32 am | by Boston Scientific | News | Comments

Company to present clinical data on its platinum chromium PROMUS® Element™ and TAXUS® Element™ Coronary Stent Systems

TOPICS:

Alere looking for $350M from notes placement

September 14, 2010 4:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Alere Inc., the Waltham life sciences firm formerly known as Inverness Medical Innovations Inc., plans to raise $350 million through a private placement of senior subordinated notes, with proceeds being used for working capital and general purposes.

Isis Pharmaceuticals to Present at the UBS Global Life Sciences Conference

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Sept. 14 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at UBS' Global Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. ET at the Grand Hyatt New...

TOPICS:
Advertisement

Quinton Oswald Named Chief Executive Officer of SARcode Corporation

September 14, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

BRISBANE, Calif., Sept. 14 /- SARcode Corporation, a privately-held biotechnology company focused on developing a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists, today announced that Quinton Oswald has joined the company as Chief Executive Officer. Mr. Oswald...

TOPICS:

TeleHealth Services and Reading Hospital and Medical Center Partner to Reach Technology-Driven Patient Education Goals

September 14, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

READING, Pa. and RALEIGH, N.C., Sept. 14 /- TeleHealth Services, the nation's leading provider of healthcare grade televisions and interactive patient education solutions, today announced a new partnership with The Reading Hospital and Medical Center (TRHMC). The 671-bed hospital chose...

TOPICS:

Stereotaxis to Present at the CL King Best Ideas Conference and the Stifel Nicolaus Healthcare Conference

September 14, 2010 3:32 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Sept. 14 /- Stereotaxis, Inc. (Nasdaq: STXS ) today announced that executive management will present at the following investor conferences: The CL King 8th Annual Best Ideas Conference to be held September 15-16, 2010 at the Omni Berkshire Place Hotel in New York City....

TOPICS:

ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firm's Growing Client Base in Germany

September 14, 2010 12:33 am | by Bio-Medicine.Org | News | Comments

FRANKFURT, Germany, Sept. 14 /- Dr. Rolf Badenhoop M.D., a 20-year veteran of the consulting and pharmaceutical industries in Europe, recently joined global sales and marketing consulting firm ZS Associates as associate principal. Badenhoop is based in the company's Frankfurt office. "I...

TOPICS:

SunEdison signs MOU for 400MW of solar projects with provincial government in Korea

September 13, 2010 10:34 pm | by I-Micronews | News | Comments

SunEdison, the solar energy development subsidiary of MEMC Electronic Materials (WFR ), and Gyeongsangnam-do ("GSND"), a provincial government in southeastern Korea, today announced the execution of a non-binding Memorandum of Understanding (MOU) for the establishment of 400 megawatts...

Advertisement

New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients

September 13, 2010 10:31 pm | by EurekAlert | News | Comments

(Burness Communications) A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announces that these same drugs -- when used long term -- may be related to unusual but serious fractures of the thigh bone.

TOPICS:

Study identifies underlying dysfunction of seemingly non-critical heart condition

September 13, 2010 10:31 pm | by EurekAlert | News | Comments

(Nationwide Children's Hospital) Repairing small, seemingly benign holes in a child's heart may be more clinically important than previously thought, as dysfunction could be lurking out of sight. These are the findings from a study conducted by doctors and researchers at Nationwide...

TOPICS:

Welsh scientists 'clone' human virus

September 13, 2010 4:37 pm | by EurekAlert | News | Comments

(Cardiff University) A team of Welsh scientists have successfully cloned a human virus offering new hope for the treatment of potentially life-threatening diseases. Human cytomegalovirus is a major infectious cause of congenital malformations worldwide. The virus is also known to...

TOPICS:

Lung transplant now viable option at any age

September 13, 2010 4:36 pm | by Baylor College of Medicine | News | Comments

Due to scientific advancements, lung transplants are a reasonable option for those dealing with end-stage lung disease at any age, according to an expert at Baylor College of Medicine . "End-stage lung disease occurs when someone loses more than 70 percent of lung function as determined...

TOPICS:

Faculty member's book profiles successful health care leaders

September 13, 2010 4:36 pm | by Arizona State University | News | Comments

ASU's Jack Gilbert has co-written a book, which challenges the view that new tools, processes and knowledge are enough to deliver the highest levels of safety, quality performance, employee engagement and financial health.read more

TOPICS:

ThermoGenesis Regains Compliance With NASDAQ Listing Rules

September 13, 2010 4:36 pm | by Bio-Medicine.Org | News | Comments

RANCHO CORDOVA, Calif., Sept. 13 /- ThermoGenesis Corp. (Nasdaq: KOOLD ), a leading supplier of innovative products and services that process and store adult stem cells, said today that it has been informed by NASDAQ that the Company is in compliance with all NASDAQ listing standards,...

TOPICS:

Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India

September 13, 2010 4:35 pm | by Bio-Medicine.Org | News | Comments

RESEARCH TRIANGLE PARK, N.C., Sept. 13 /- Max Neeman International, a leading Indian CRO, announces the expansion of therapeutic focused device clinical trial services in India. Max Neeman has formed an experienced and world class team of medical device experts specializing in carrying...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading